{ "source": "Nasdaq Nordic Company News", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "status": "retrieved", "company": "Active Biotech", "reports": [ { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:47:16Z", "company": "Active Biotech AB", "title": "Active Biotech Delårsrapport Q1 2026", "category": "Interimsrapport", "date": "2026-05-07", "language": "sv", "report_type": "interim-report", "fiscal_year": 2026, "quarter": "q1", "period": "2026-q1", "report_key": "2026:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=bee48b273a4f615b8fb942a861d58aa1a&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2026-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2026-q1\\release.txt", "attachments": [ { "label": "Active Biotech Rapport 2026 Q1 Sve.pdf", "url": "https://attachment.news.eu.nasdaq.com/aa9154e51b3d97e5e453283ca69f7982a", "final_url": "https://attachment.news.eu.nasdaq.com/aa9154e51b3d97e5e453283ca69f7982a", "filename": "Active_Biotech_Rapport_2026_Q1_Sve.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2026-q1\\Active_Biotech_Rapport_2026_Q1_Sve.pdf", "content_type": "application/pdf", "size": 460261, "sha256": "e250c958f1f47dd069c5af84cd6f79ff434a8dd18adfbe6d65b227a9ad69c337", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2026-q1\\Active_Biotech_Rapport_2026_Q1_Sve.pdf", "filename": "Active_Biotech_Rapport_2026_Q1_Sve.pdf", "extension": ".pdf", "size": 460261, "sha256": "e250c958f1f47dd069c5af84cd6f79ff434a8dd18adfbe6d65b227a9ad69c337", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2026-q1\\extracted\\Active_Biotech_Rapport_2026_Q1_Sve\\Active_Biotech_Rapport_2026_Q1_Sve.txt", "text_chars": 49140, "metadata": { "page_count": 20, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2026-q1\\extracted\\Active_Biotech_Rapport_2026_Q1_Sve\\Active_Biotech_Rapport_2026_Q1_Sve.extraction.json" } } ], "announcement_id": "1440510", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:47:30Z", "company": "Active Biotech AB", "title": "Årsredovisning 2025 Active Biotech AB (publ)", "category": "Bokslut och Verksamhetsberättelse", "date": "2026-04-01", "language": "sv", "report_type": "annual-report", "fiscal_year": 2025, "quarter": "annual", "period": "2025-annual", "report_key": "2025:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=bc60641b2a257ed8ab19c1b17b5ec5efc&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-annual\\release.txt", "attachments": [ { "label": "Active Biotech 2025 Sve.pdf", "url": "https://attachment.news.eu.nasdaq.com/a021c93eb2bff7249e5f5fdf0518a9c4b", "final_url": "https://attachment.news.eu.nasdaq.com/a021c93eb2bff7249e5f5fdf0518a9c4b", "filename": "Active_Biotech_2025_Sve.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-annual\\Active_Biotech_2025_Sve.pdf", "content_type": "application/pdf", "size": 7961270, "sha256": "88bf9db8a8abec5d77d1333dc40e9fc0c94fa3a357c6501b67d9985bc8247a9b", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-annual\\Active_Biotech_2025_Sve.pdf", "filename": "Active_Biotech_2025_Sve.pdf", "extension": ".pdf", "size": 7961270, "sha256": "88bf9db8a8abec5d77d1333dc40e9fc0c94fa3a357c6501b67d9985bc8247a9b", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-annual\\extracted\\Active_Biotech_2025_Sve\\Active_Biotech_2025_Sve.txt", "text_chars": 283895, "metadata": { "page_count": 101, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-annual\\extracted\\Active_Biotech_2025_Sve\\Active_Biotech_2025_Sve.extraction.json" } } ], "announcement_id": "1430729", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:47:32Z", "company": "Active Biotech AB", "title": "Active Biotech Bokslutsrapport 2025", "category": "Bokslutskommuniké", "date": "2026-02-12", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2025, "quarter": "q4", "period": "2025-q4", "report_key": "2025:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b05fe5be301b2d2469e148da1273a9c7b&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q4\\release.txt", "attachments": [ { "label": "Active Biotech Rapport 2025 Q4 Sve.pdf", "url": "https://attachment.news.eu.nasdaq.com/aca159b19464ce4a453db1195556593e8", "final_url": "https://attachment.news.eu.nasdaq.com/aca159b19464ce4a453db1195556593e8", "filename": "Active_Biotech_Rapport_2025_Q4_Sve.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q4\\Active_Biotech_Rapport_2025_Q4_Sve.pdf", "content_type": "application/pdf", "size": 510615, "sha256": "51d53e436a17b0f7117d184eeec2af8688c0ff7fe40da65c08c7e7435c05d449", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q4\\Active_Biotech_Rapport_2025_Q4_Sve.pdf", "filename": "Active_Biotech_Rapport_2025_Q4_Sve.pdf", "extension": ".pdf", "size": 510615, "sha256": "51d53e436a17b0f7117d184eeec2af8688c0ff7fe40da65c08c7e7435c05d449", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q4\\extracted\\Active_Biotech_Rapport_2025_Q4_Sve\\Active_Biotech_Rapport_2025_Q4_Sve.txt", "text_chars": 54948, "metadata": { "page_count": 22, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q4\\extracted\\Active_Biotech_Rapport_2025_Q4_Sve\\Active_Biotech_Rapport_2025_Q4_Sve.extraction.json" } } ], "announcement_id": "1419762", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:47:37Z", "company": "Active Biotech AB", "title": "Active Biotech delårsrapport Q3 2025", "category": "Interimsrapport", "date": "2025-11-06", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q3", "period": "2025-q3", "report_key": "2025:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b5322e87a44419553cc1746c567ae2fd0&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q3\\release.txt", "attachments": [ { "label": "Active Biotech Rapport 2025 Q3 Sve.pdf", "url": "https://attachment.news.eu.nasdaq.com/a72cf8adad377196c5f57d9153e93fe7b", "final_url": "https://attachment.news.eu.nasdaq.com/a72cf8adad377196c5f57d9153e93fe7b", "filename": "Active_Biotech_Rapport_2025_Q3_Sve.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q3\\Active_Biotech_Rapport_2025_Q3_Sve.pdf", "content_type": "application/pdf", "size": 521416, "sha256": "d1480f822f3ddd272476ed46d0c6a45cb5ba32c625da8685b3ca91513738d4a4", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q3\\Active_Biotech_Rapport_2025_Q3_Sve.pdf", "filename": "Active_Biotech_Rapport_2025_Q3_Sve.pdf", "extension": ".pdf", "size": 521416, "sha256": "d1480f822f3ddd272476ed46d0c6a45cb5ba32c625da8685b3ca91513738d4a4", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q3\\extracted\\Active_Biotech_Rapport_2025_Q3_Sve\\Active_Biotech_Rapport_2025_Q3_Sve.txt", "text_chars": 62633, "metadata": { "page_count": 24, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q3\\extracted\\Active_Biotech_Rapport_2025_Q3_Sve\\Active_Biotech_Rapport_2025_Q3_Sve.extraction.json" } } ], "announcement_id": "1399098", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:47:42Z", "company": "Active Biotech AB", "title": "DELÅRSRAPPORT Q2 2025", "category": "Halvårsrapport", "date": "2025-08-21", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q2", "period": "2025-q2", "report_key": "2025:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b7e1ca8a151719b1e37058ff128147e77&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q2\\release.txt", "attachments": [ { "label": "Active Biotech Rapport 2025 Q2 Sve.pdf", "url": "https://attachment.news.eu.nasdaq.com/a2eccc638698c9f2aea2022c142042bb7", "final_url": "https://attachment.news.eu.nasdaq.com/a2eccc638698c9f2aea2022c142042bb7", "filename": "Active_Biotech_Rapport_2025_Q2_Sve.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q2\\Active_Biotech_Rapport_2025_Q2_Sve.pdf", "content_type": "application/pdf", "size": 509579, "sha256": "85660e7863f0fe0d042a855e88c9e3f23ad15b38847790e7a9faeee8a7ee3425", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q2\\Active_Biotech_Rapport_2025_Q2_Sve.pdf", "filename": "Active_Biotech_Rapport_2025_Q2_Sve.pdf", "extension": ".pdf", "size": 509579, "sha256": "85660e7863f0fe0d042a855e88c9e3f23ad15b38847790e7a9faeee8a7ee3425", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q2\\extracted\\Active_Biotech_Rapport_2025_Q2_Sve\\Active_Biotech_Rapport_2025_Q2_Sve.txt", "text_chars": 58751, "metadata": { "page_count": 23, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q2\\extracted\\Active_Biotech_Rapport_2025_Q2_Sve\\Active_Biotech_Rapport_2025_Q2_Sve.extraction.json" } } ], "announcement_id": "1384473", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:47:48Z", "company": "Active Biotech AB", "title": "Active Biotech delårsrapport Q1 2025", "category": "Interimsrapport", "date": "2025-05-08", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q1", "period": "2025-q1", "report_key": "2025:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b055430f65efaa49c622e229c9385e108&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q1\\release.txt", "attachments": [ { "label": "Active Biotech Rapport 2025 Q1 Sve.pdf", "url": "https://attachment.news.eu.nasdaq.com/aecd93218278374230f26f6f12d3c90ea", "final_url": "https://attachment.news.eu.nasdaq.com/aecd93218278374230f26f6f12d3c90ea", "filename": "Active_Biotech_Rapport_2025_Q1_Sve.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q1\\Active_Biotech_Rapport_2025_Q1_Sve.pdf", "content_type": "application/pdf", "size": 416133, "sha256": "2a217ea547a4d70cd9d87ff1aa88f1542037927c5188e4337bea8524a4c46526", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q1\\Active_Biotech_Rapport_2025_Q1_Sve.pdf", "filename": "Active_Biotech_Rapport_2025_Q1_Sve.pdf", "extension": ".pdf", "size": 416133, "sha256": "2a217ea547a4d70cd9d87ff1aa88f1542037927c5188e4337bea8524a4c46526", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q1\\extracted\\Active_Biotech_Rapport_2025_Q1_Sve\\Active_Biotech_Rapport_2025_Q1_Sve.txt", "text_chars": 57126, "metadata": { "page_count": 22, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2025-q1\\extracted\\Active_Biotech_Rapport_2025_Q1_Sve\\Active_Biotech_Rapport_2025_Q1_Sve.extraction.json" } } ], "announcement_id": "1361803", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:48:03Z", "company": "Active Biotech AB", "title": "Årsredovisning 2024 Active Biotech AB (publ)", "category": "Bokslut och Verksamhetsberättelse", "date": "2025-04-07", "language": "sv", "report_type": "annual-report", "fiscal_year": 2024, "quarter": "annual", "period": "2024-annual", "report_key": "2024:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b724053a13819d17ec1c9048701f12842&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-annual\\release.txt", "attachments": [ { "label": "Active Biotech 2024 Sve.pdf", "url": "https://attachment.news.eu.nasdaq.com/ab29fe1da63c9680f3d6aad7159c9a6da", "final_url": "https://attachment.news.eu.nasdaq.com/ab29fe1da63c9680f3d6aad7159c9a6da", "filename": "Active_Biotech_2024_Sve.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-annual\\Active_Biotech_2024_Sve.pdf", "content_type": "application/pdf", "size": 6464402, "sha256": "97a68ebdc4b298c49c560a2d6c993da29fdb93c16e92d9b0b3b6789ccc1e917e", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-annual\\Active_Biotech_2024_Sve.pdf", "filename": "Active_Biotech_2024_Sve.pdf", "extension": ".pdf", "size": 6464402, "sha256": "97a68ebdc4b298c49c560a2d6c993da29fdb93c16e92d9b0b3b6789ccc1e917e", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-annual\\extracted\\Active_Biotech_2024_Sve\\Active_Biotech_2024_Sve.txt", "text_chars": 307165, "metadata": { "page_count": 106, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-annual\\extracted\\Active_Biotech_2024_Sve\\Active_Biotech_2024_Sve.extraction.json" } } ], "announcement_id": "1354155", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:48:05Z", "company": "Active Biotech AB", "title": "Active Biotech Bokslutsrapport 2024", "category": "Bokslutskommuniké", "date": "2025-02-13", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2024, "quarter": "q4", "period": "2024-q4", "report_key": "2024:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=ba5d12534fe6e12b43c25214f5fba7086&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q4\\release.txt", "attachments": [ { "label": "Active Biotech Rapport 2024 Q4 Sve.pdf", "url": "https://attachment.news.eu.nasdaq.com/a3ec16aacb121a02bfd3f46ba313c9765", "final_url": "https://attachment.news.eu.nasdaq.com/a3ec16aacb121a02bfd3f46ba313c9765", "filename": "Active_Biotech_Rapport_2024_Q4_Sve.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q4\\Active_Biotech_Rapport_2024_Q4_Sve.pdf", "content_type": "application/pdf", "size": 523650, "sha256": "1d489c064de78126550f227dfaa46219d75dcc06c14bea92c16e7282d4d53600", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q4\\Active_Biotech_Rapport_2024_Q4_Sve.pdf", "filename": "Active_Biotech_Rapport_2024_Q4_Sve.pdf", "extension": ".pdf", "size": 523650, "sha256": "1d489c064de78126550f227dfaa46219d75dcc06c14bea92c16e7282d4d53600", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q4\\extracted\\Active_Biotech_Rapport_2024_Q4_Sve\\Active_Biotech_Rapport_2024_Q4_Sve.txt", "text_chars": 62464, "metadata": { "page_count": 23, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q4\\extracted\\Active_Biotech_Rapport_2024_Q4_Sve\\Active_Biotech_Rapport_2024_Q4_Sve.extraction.json" } } ], "announcement_id": "1342716", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:48:11Z", "company": "Active Biotech AB", "title": "Active Biotech Delårsrapport Q3 2024", "category": "Interimsrapport", "date": "2024-10-21", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q3", "period": "2024-q3", "report_key": "2024:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=bd007a591d56967abc41a0e1a5dbafd77&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q3\\release.txt", "attachments": [ { "label": "AB Rapport 2024 Q3 Sv.pdf", "url": "https://attachment.news.eu.nasdaq.com/a4bc6d31be9beb9745e1e34b0e4a1edc4", "final_url": "https://attachment.news.eu.nasdaq.com/a4bc6d31be9beb9745e1e34b0e4a1edc4", "filename": "AB_Rapport_2024_Q3_Sv.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q3\\AB_Rapport_2024_Q3_Sv.pdf", "content_type": "application/pdf", "size": 535244, "sha256": "77a80580a0321f6c96d9a9f0e4c774c403e922a97bb83990046a2a7ec0f28e58", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q3\\AB_Rapport_2024_Q3_Sv.pdf", "filename": "AB_Rapport_2024_Q3_Sv.pdf", "extension": ".pdf", "size": 535244, "sha256": "77a80580a0321f6c96d9a9f0e4c774c403e922a97bb83990046a2a7ec0f28e58", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q3\\extracted\\AB_Rapport_2024_Q3_Sv\\AB_Rapport_2024_Q3_Sv.txt", "text_chars": 63888, "metadata": { "page_count": 25, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q3\\extracted\\AB_Rapport_2024_Q3_Sv\\AB_Rapport_2024_Q3_Sv.extraction.json" } } ], "announcement_id": "1322484", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:48:17Z", "company": "Active Biotech AB", "title": "Active Biotech delårsrapport Q2 2024", "category": "Halvårsrapport", "date": "2024-08-22", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q2", "period": "2024-q2", "report_key": "2024:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b3fe2cf10af9bff7a22824dc89c4c966c&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q2\\release.txt", "attachments": [ { "label": "AB Rapport 2024 Q2 Sv.pdf", "url": "https://attachment.news.eu.nasdaq.com/ac3cca813fd679370e9c4112973da021a", "final_url": "https://attachment.news.eu.nasdaq.com/ac3cca813fd679370e9c4112973da021a", "filename": "AB_Rapport_2024_Q2_Sv.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q2\\AB_Rapport_2024_Q2_Sv.pdf", "content_type": "application/pdf", "size": 511051, "sha256": "f362dcc495266d00e8080a3417b90aacf73918d44a5706df3b43740adc2c07da", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q2\\AB_Rapport_2024_Q2_Sv.pdf", "filename": "AB_Rapport_2024_Q2_Sv.pdf", "extension": ".pdf", "size": 511051, "sha256": "f362dcc495266d00e8080a3417b90aacf73918d44a5706df3b43740adc2c07da", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q2\\extracted\\AB_Rapport_2024_Q2_Sv\\AB_Rapport_2024_Q2_Sv.txt", "text_chars": 55542, "metadata": { "page_count": 21, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q2\\extracted\\AB_Rapport_2024_Q2_Sv\\AB_Rapport_2024_Q2_Sv.extraction.json" } } ], "announcement_id": "1312203", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:48:23Z", "company": "Active Biotech AB", "title": "Active Biotech delårsrapport Q1 2024", "category": "Interimsrapport", "date": "2024-05-08", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q1", "period": "2024-q1", "report_key": "2024:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b95302693ae6c1569f65cf4eb490aeb94&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q1\\release.txt", "attachments": [ { "label": "AB Rapport 2024 Q1 Sv.pdf", "url": "https://attachment.news.eu.nasdaq.com/a17370e61d30ce886f91e99fb458bf4a7", "final_url": "https://attachment.news.eu.nasdaq.com/a17370e61d30ce886f91e99fb458bf4a7", "filename": "AB_Rapport_2024_Q1_Sv.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q1\\AB_Rapport_2024_Q1_Sv.pdf", "content_type": "application/pdf", "size": 569700, "sha256": "84816ad79acd600c1002df056671c601cd5f3a9014bfa8a375e6691dfc05cd20", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q1\\AB_Rapport_2024_Q1_Sv.pdf", "filename": "AB_Rapport_2024_Q1_Sv.pdf", "extension": ".pdf", "size": 569700, "sha256": "84816ad79acd600c1002df056671c601cd5f3a9014bfa8a375e6691dfc05cd20", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q1\\extracted\\AB_Rapport_2024_Q1_Sv\\AB_Rapport_2024_Q1_Sv.txt", "text_chars": 59047, "metadata": { "page_count": 23, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2024-q1\\extracted\\AB_Rapport_2024_Q1_Sv\\AB_Rapport_2024_Q1_Sv.extraction.json" } } ], "announcement_id": "1294605", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:48:35Z", "company": "Active Biotech AB", "title": "Årsredovisning 2023 Active Biotech AB (publ)", "category": "Bokslut och Verksamhetsberättelse", "date": "2024-04-22", "language": "sv", "report_type": "annual-report", "fiscal_year": 2023, "quarter": "annual", "period": "2023-annual", "report_key": "2023:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=bb8e999164dd059108f90c64638ef95a3&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-annual\\release.txt", "attachments": [ { "label": "Active Biotech 2023 Sve.pdf", "url": "https://attachment.news.eu.nasdaq.com/ae773646c51c9e2f2a2f1168fc7e5e9ac", "final_url": "https://attachment.news.eu.nasdaq.com/ae773646c51c9e2f2a2f1168fc7e5e9ac", "filename": "Active_Biotech_2023_Sve.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-annual\\Active_Biotech_2023_Sve.pdf", "content_type": "application/pdf", "size": 7794203, "sha256": "dc8762605d28fa90683f0dd2f7360f7014cb8a2b80a66c487a1e0c0e45bfe00b", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-annual\\Active_Biotech_2023_Sve.pdf", "filename": "Active_Biotech_2023_Sve.pdf", "extension": ".pdf", "size": 7794203, "sha256": "dc8762605d28fa90683f0dd2f7360f7014cb8a2b80a66c487a1e0c0e45bfe00b", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-annual\\extracted\\Active_Biotech_2023_Sve\\Active_Biotech_2023_Sve.txt", "text_chars": 309681, "metadata": { "page_count": 103, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-annual\\extracted\\Active_Biotech_2023_Sve\\Active_Biotech_2023_Sve.extraction.json" } } ], "announcement_id": "1289345", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:48:38Z", "company": "Active Biotech AB", "title": "Active Biotech Bokslutsrapport 2023", "category": "Bokslutskommuniké", "date": "2024-02-08", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2023, "quarter": "q4", "period": "2023-q4", "report_key": "2023:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b604c9fbb9e1d09c0c4de418aee6a072c&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q4\\release.txt", "attachments": [ { "label": "Ab Rapport 2023 Q4 Sve.pdf", "url": "https://attachment.news.eu.nasdaq.com/a8f42024facc84fdf446634de9530a785", "final_url": "https://attachment.news.eu.nasdaq.com/a8f42024facc84fdf446634de9530a785", "filename": "Ab_Rapport_2023_Q4_Sve.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q4\\Ab_Rapport_2023_Q4_Sve.pdf", "content_type": "application/pdf", "size": 756916, "sha256": "ebce3b66d7388f46aa065db4f459da99c780abd5e9e1d65e7b797b6e9110c902", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q4\\Ab_Rapport_2023_Q4_Sve.pdf", "filename": "Ab_Rapport_2023_Q4_Sve.pdf", "extension": ".pdf", "size": 756916, "sha256": "ebce3b66d7388f46aa065db4f459da99c780abd5e9e1d65e7b797b6e9110c902", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q4\\extracted\\Ab_Rapport_2023_Q4_Sve\\Ab_Rapport_2023_Q4_Sve.txt", "text_chars": 60458, "metadata": { "page_count": 22, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q4\\extracted\\Ab_Rapport_2023_Q4_Sve\\Ab_Rapport_2023_Q4_Sve.extraction.json" } } ], "announcement_id": "1273536", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:48:43Z", "company": "Active Biotech AB", "title": "Active Biotech Delårsrapport Q3 2023", "category": "Interimsrapport", "date": "2023-11-09", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q3", "period": "2023-q3", "report_key": "2023:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=ba27eb7833d20e502021a62a0e3c7871a&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q3\\release.txt", "attachments": [ { "label": "AB Rapport 2023 Q3 Sve.pdf", "url": "https://attachment.news.eu.nasdaq.com/acb03ff15ede6f7e732c107c1215c31a2", "final_url": "https://attachment.news.eu.nasdaq.com/acb03ff15ede6f7e732c107c1215c31a2", "filename": "AB_Rapport_2023_Q3_Sve.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q3\\AB_Rapport_2023_Q3_Sve.pdf", "content_type": "application/pdf", "size": 528799, "sha256": "0ab6e23509f4801ef2e4592682fcfbdde699b9c747c21cb5f55148a17450a0b4", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q3\\AB_Rapport_2023_Q3_Sve.pdf", "filename": "AB_Rapport_2023_Q3_Sve.pdf", "extension": ".pdf", "size": 528799, "sha256": "0ab6e23509f4801ef2e4592682fcfbdde699b9c747c21cb5f55148a17450a0b4", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q3\\extracted\\AB_Rapport_2023_Q3_Sve\\AB_Rapport_2023_Q3_Sve.txt", "text_chars": 57125, "metadata": { "page_count": 22, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q3\\extracted\\AB_Rapport_2023_Q3_Sve\\AB_Rapport_2023_Q3_Sve.extraction.json" } } ], "announcement_id": "1258189", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:48:49Z", "company": "Active Biotech AB", "title": "Active Biotech Delårsrapport Q2 2023", "category": "Halvårsrapport", "date": "2023-08-24", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q2", "period": "2023-q2", "report_key": "2023:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b51bf50e9e3c53c4feff148794f44717d&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q2\\release.txt", "attachments": [ { "label": "AB Rapport 2023 Q2 Sve.pdf", "url": "https://attachment.news.eu.nasdaq.com/a7c98e6507d7d6797788f40ef09b5d08c", "final_url": "https://attachment.news.eu.nasdaq.com/a7c98e6507d7d6797788f40ef09b5d08c", "filename": "AB_Rapport_2023_Q2_Sve.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q2\\AB_Rapport_2023_Q2_Sve.pdf", "content_type": "application/pdf", "size": 529409, "sha256": "c636f03354ee1882c569d5de9cded35144067806557ae0a625d1ba32984715d8", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q2\\AB_Rapport_2023_Q2_Sve.pdf", "filename": "AB_Rapport_2023_Q2_Sve.pdf", "extension": ".pdf", "size": 529409, "sha256": "c636f03354ee1882c569d5de9cded35144067806557ae0a625d1ba32984715d8", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q2\\extracted\\AB_Rapport_2023_Q2_Sve\\AB_Rapport_2023_Q2_Sve.txt", "text_chars": 54776, "metadata": { "page_count": 21, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q2\\extracted\\AB_Rapport_2023_Q2_Sve\\AB_Rapport_2023_Q2_Sve.extraction.json" } } ], "announcement_id": "1244212", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T00:48:53Z", "company": "Active Biotech AB", "title": "Active Biotech Delårsrapport Q1 2023", "category": "Interimsrapport", "date": "2023-05-04", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q1", "period": "2023-q1", "report_key": "2023:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b41ea85cce40bfd5a91f91d5edf20a595&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q1\\release.txt", "attachments": [ { "label": "Ab Rapport 2023 Q1 Sv.pdf", "url": "https://attachment.news.eu.nasdaq.com/ad79d1d4f816db9df4983e5c20a487f00", "final_url": "https://attachment.news.eu.nasdaq.com/ad79d1d4f816db9df4983e5c20a487f00", "filename": "Ab_Rapport_2023_Q1_Sv.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q1\\Ab_Rapport_2023_Q1_Sv.pdf", "content_type": "application/pdf", "size": 486204, "sha256": "1df5459e6d41478ac51332604cb705bb83ffdeba18557359b0ecd6e222cccb10", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q1\\Ab_Rapport_2023_Q1_Sv.pdf", "filename": "Ab_Rapport_2023_Q1_Sv.pdf", "extension": ".pdf", "size": 486204, "sha256": "1df5459e6d41478ac51332604cb705bb83ffdeba18557359b0ecd6e222cccb10", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q1\\extracted\\Ab_Rapport_2023_Q1_Sv\\Ab_Rapport_2023_Q1_Sv.txt", "text_chars": 49168, "metadata": { "page_count": 19, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\active-biotech\\nasdaq-reports\\reports\\2023-q1\\extracted\\Ab_Rapport_2023_Q1_Sv\\Ab_Rapport_2023_Q1_Sv.extraction.json" } } ], "announcement_id": "1225374", "status": "retrieved" } ], "attempts": [ { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "85c264ef4138e3710a3a9159ca36720292e4d5111e2da3e088cda4c871566605" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "1651afa1b60e0d2649af793e05cc3134990fedc7df71e667eb303129822db49a" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 200, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "c1eb22f13924d053a60edf85bee546b15b552aca2d32b04f2487951c0994d73c" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 300, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "e07887ae8f0316e297faa93424b7592245bb56ff4921f45af73306ad1a501045" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=400&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 400, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "07f4eebc5d6e4f79256d8a3df56626337a8d4243ff3841f66fcdd4441fe8dcff" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=500&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 500, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 46, "new_rows": 46, "total_count": null, "from_cache": false, "body_sha256": "8da2878ff6d61aeae609e337e4ff06d790de9863545dfcbfbe6f7208dd621190" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 34, "new_rows": 34, "total_count": null, "from_cache": false, "body_sha256": "e8bf55eaf1d88167657422aedab09bb0391740785c42894066dd814c22334e08" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=34&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 34, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "8c7fb72d902b0d6cf2bbe6334a6aa21df9a6889a7751279d4d1cb3e4389f7cbe" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "6392088eb8d46a4a5a5561aff1d9bdfbed246a817499fbe5ea5f9c6048b7ed00" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "0a9ceb1a75b67641eacbc27ca67fd17336b3a76b13d82124eff3bb33e204912d" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 200, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "67c0a595662a69d4a8dd6c666c111da029ef0eed04c002465656402682787b7e" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 300, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "9d8c302d3397dcd33b7d5da4eb7376ea072b72ec82630c80181c9a2b7f51ec61" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=400&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 400, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "cfef0fa5da6a038cf3983cc038e109bdc5491026228d8cb5821099e6ab4cecd6" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=500&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 500, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "21272a9c40d29af7f3ea70e653abb1874be8919a6b10acc8b27f7f4cc01a848a" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "7ba29606cd6416c80821572843254341f75cefc0bc95f1d78b7bf5552263fb36" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "308f52ddecae9daa3428e304d72b10328e6edcf4297860b5cdf1e4f2b1bc257e" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 200, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "40bdfb705e23856ba1842011462fbfcf02e95d7fe0eb5fc1c7387e4802f54090" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 300, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "6beb1cd44ffd5259fa0f4e67d8cefb4a6b95a7a7c442e832a7f3d472dc18bc50" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=400&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 400, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 48, "new_rows": 48, "total_count": null, "from_cache": false, "body_sha256": "708ecb5a0f1df291376e3273b57c1a165913a7053cf0bff80bb07b4dd50f0472" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Active+Biotech&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=448&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 448, "pagination": "row-offset", "query_text": "Active Biotech", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "ef0c2a71694b12de4c6fbce0c3c5c3b9f2c7b4f94e6d7341bd1932169da06b21" } ], "identity": { "slug": "", "instrument_id": "TX139", "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/acti?id=TX139" }, "transport": "ordinary-http", "browser_used": false, "query_text": "Active Biotech", "retrieved_at": "2026-08-07T00:48:53Z" }